Navigation Links
First web-based prostate cancer database launches
Date:10/25/2012

LOS ANGELES - EMBARGOED UNTIL 6 A.M. EDT ON OCT. 24, 2012 The National Proactive Surveillance Network, the world's first online medical database designed to help men track the progression of their prostate cancer while avoiding complications from overtreatment, launches today.

A project of the Prostate Cancer Foundation, the Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute and Johns Hopkins, the National Proactive Surveillance Network will allow men diagnosed with slow-growing forms of the disease to track their disease in a secure, interactive web-based patient portal.

"Recently, new research has estimated that as many as 50 percent of newly diagnosed prostate cancer patients have a form of the disease that is so slow-growing that it often does not pose a threat to the life or long term health of the patient," said Stuart Holden, MD, director of Cedars-Sinai's Louis Warschaw Prostate Cancer Center and medical director for the Prostate Cancer Foundation. "As a result, a growing number of prostate cancer patients are deciding that the best course of action for them may be to defer initial treatment until it can be determined whether they, in fact, have the more aggressive or less aggressive form of the disease." Traditionally, men diagnosed with early-stage prostate cancer choose immediate treatment, such as surgery or radiation. Such aggressive treatment can result in complications such as impotence and incontinence, diminishing quality of life while not increasing the patient's lifespan, said Holden, who also holds the Warschaw, Robertson, Law Families Chair in Prostate Cancer at Cedars-Sinai.

That recognition has led some doctors offer patients a new option: "Proactive surveillance" also known as "watchful waiting" or "active surveillance". In proactive surveillance, patients thought to have early-stage or slow-growing forms of the disease are closely monitored. If a patient's cancer accelerates, then more aggressive treatment options can be safely employed.

"We aren't advocating that any patient choose proactive surveillance," said Edwin M. Posadas, MD, medical director of the Urologic Oncology Program at Cedars-Sinai's Samuel Oschin Comprehensive Cancer Institute. "But if a patient and his doctor think this is the right course for that particular patient, then he can opt in and help medical science collect the invaluable data that scientists need to develop new tests and new treatments."

Patients who opt into joining the National Proactive Surveillance Network would undergo yearly prostate biopsies, answer extensive lifestyle and nutrition questionnaires and record their medical histories. Changes in their disease would be tracked online, allowing patients to decide whether and/or when to change the course of their treatment. The Network will collect and sort data blindlywith absolutely no patient name associationso researchers can analyze trends as well as patient commonalities and differences.

Patient samples, including biopsy tissue, blood and urine, also will be analyzed and banked by Johns Hopkins Medicine on the east coast and Cedars-Sinai Medical Center in the west and used in future prostate cancer studies. This will be the first comprehensive clinical data and tissue collection from a group of men with early-stage, low-volume prostate cancer. Researchers also will be able to examine and test the tissue to discover critical changes which can indicate whether patients have slow- or fast-growing forms of prostate cancer.

"This database will eventually give us a better way to predict which men benefit from treatment and which men will not be harmed by choosing to defer treatment," Holden said. "Whether to undergo initial treatment or to engage in proactive surveillance is a personal decision that a patient makes after consulting with their own doctors and family members. For those who choose to wait and monitor their condition, the National Proactive Surveillance Network will be a tremendous resource. And for medical professionals, this program will enable us to more effectively treat patients while avoiding complications."


'/>"/>

Contact: Sally Stewart
sally.stewart@cshs.org
310-248-6566
Cedars-Sinai Medical Center
Source:Eurekalert

Related medicine news :

1. BIDMC and Diagnostics For All create first low-cost, paper-based, point of care liver function test
2. FDA OKs First Ultrasound Imaging System for Dense Breasts
3. AIUM accredits first urological practice
4. First Pathfinder Awards announced tackling rare and orphan diseases
5. JDRF announces winners of first phase of Agnes Varis Glucose-Responsive Insulin Challenge
6. CRF announces late breaking trials and first report investigations to be presented at TCT 2012
7. Three Penn State research pioneers among first Golden Goose honorees
8. Eight scientists honored in first annual Golden Goose Awards
9. First comprehensive review of European breast cancer screening programs finds benefits outweigh harm
10. First pediatric study to look at the role of vitamin D in critical illness
11. Researchers find first evidence for a genetic cause for Barretts esophagus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief ... a minimum wage raise to $12 an hour by 2020 and then adjusting it yearly ... lost value of the minimum wage, assure the wage floor does not erode again, and ...
(Date:6/24/2016)... Georgia (PRWEB) , ... June 24, 2016 , ... ... awards today at the Clinical Decision Making in Emergency Medicine conference in Ponte ... have authored journal articles published in Emergency Medicine Practice and Pediatric ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & ... (TGIG), has initiated cultivation and processing operations at its production facility, and opened ... , Puradigm is the manufacturer of a complete system of proactive air and ...
(Date:6/24/2016)... ... ... National recruitment firm Slone Partners is pleased to announce the placement of ... President of North American Capital Sales at HTG Molecular . , ... the commercialization of the HTG EdgeSeq system and associated reagents in North America. , ...
(Date:6/24/2016)... ... June 24, 2016 , ... Today, MTI-GlobalStem, a ... cells and other difficult to transfect cells, announces its launch of the PluriQ™ ... Gene Editing System is a complete system for culturing and transfecting human ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016 Research and Markets ... for Companion Diagnostic Tests" report to their offering. ... Companion Diagnostics The World Market for Companion ... medicine diagnostics. Market analysis in the report includes the following: ... (In Vitro Diagnostic Kits) by Region (N. America, EU, ROW), ...
(Date:6/24/2016)... Belgium , June 24, 2016 /PRNewswire/ ... announced the appointment of Dr. Edward Futcher ... a Non-Executive Director, effective June 23, 2016.Dr. Futcher ... and Nominations and Governance Committees.  As a non-executive ... provide independent expertise and strategic counsel to VolitionRx ...
(Date:6/23/2016)... , June 23, 2016 Research ... Devices Global Market - Forecast to 2022" report to ... the treatment method for the patients with kidney failure, it ... excess fluid from the patient,s blood and thus the treatment ... potassium and chloride in balance. Increasing number ...
Breaking Medicine Technology: